The xMAP® SARS-CoV-2 Multi-Antigen IgG Assay is a serological, multiplexed microsphere-based assay to measure the presence of IgG antibodies directed against the nucleocapsid protein (N), Receptor-Binding Domain (RBD) of the spike protein, and the S1 subunit of the spike protein (S1) of SARS-CoV-2 in human serum or plasma.
The xMAP SARS-CoV-2 Multi-Antigen IgG Assay features:
For Research Use Only. Not for use in diagnostic procedures.
Manufacturer Luminex | Available Worldwide
Be the first to review this product